Showing results (51-60 of 476) with videos related to

Sort By:
Pageof 48
Journal of Cardiac Failure|May 13, 2022
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure PopulationTonje Thorvaldsen, Giulia Ferrannini, Linda Mellbin, et al.
Cardiac Failure Review|September 13, 2018
Heart Failure with Mid-range Ejection Fraction: Lessons from CHARMLars H Lund
ESC Heart Failure|November 23, 2021
Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trialLars H Lund, Gianluigi Savarese, Ashwin Venkateshvaran, et al.
European Journal of Heart Failure|March 12, 2022
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strataDavide Stolfo, Lars H Lund, Peter Moritz Becher, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
Journal of Cardiac Failure|June 22, 2016
HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1Ulrika Ljung Faxén, Camilla Hage, Lina Benson, et al.
JAMA Cardiology|October 22, 2025
Short-Term Exposure to Low and High Temperatures and Mortality Among Patients With Heart Failure in SwedenWenli Ni, Lina Benson, Petter Ljungman, et al.
Pageof 48